{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T13:02:15Z","timestamp":1776258135225,"version":"3.50.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T00:00:00Z","timestamp":1766793600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T00:00:00Z","timestamp":1766793600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s12185-025-04146-2","type":"journal-article","created":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T13:02:27Z","timestamp":1766840547000},"page":"607-610","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A case of SCD controlled by IMiDs and hydroxyurea"],"prefix":"10.1007","volume":"123","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3341-9057","authenticated-orcid":false,"given":"Ashrei","family":"Bayewitz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sai Shalini","family":"Pillarisetty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Moeini Nia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,27]]},"reference":[{"issue":"6","key":"4146_CR1","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1097\/00006254-194812000-00022","volume":"3","author":"J Watson","year":"1948","unstructured":"Watson J, Stahman AW, Bilello FP. The significance of the paucity of sickle cells in newborn Negro infants. Obstet Gynecol Surv. 1948;3(6):819\u201320.","journal-title":"Obstet Gynecol Surv"},{"issue":"21","key":"4146_CR2","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1182\/blood.2020007645","volume":"136","author":"MH Steinberg","year":"2020","unstructured":"Steinberg MH. Fetal hemoglobin in sickle cell anemia. Blood. 2020;136(21):2392\u2013400.","journal-title":"Blood"},{"issue":"18","key":"4146_CR3","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1056\/NEJM199505183322001","volume":"332","author":"S Charache","year":"1995","unstructured":"Charache S, Terrin ML, Moore RD, Dover GJ, Barton FB, Eckert SV, et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N Engl J Med. 1995;332(18):1317\u201322. https:\/\/doi.org\/10.1056\/NEJM199505183322001.","journal-title":"N Engl J Med"},{"issue":"1","key":"4146_CR4","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1172\/JCI32322","volume":"118","author":"LA de Moutouh- Parseval","year":"2008","unstructured":"de Moutouh- Parseval LA, Verhelle D, Glezer E, Jensen-Pergakes K, Ferguson GD, Corral LG, et al. Pomalidomide and lenalidomide regulate erythropoiesis and fetal hemoglobin production in human CD34+ cells. J Clin Invest. 2008;118(1):248\u201358.","journal-title":"J Clin Invest"},{"issue":"21","key":"4146_CR5","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1182\/blood.V122.21.777.777","volume":"122","author":"A Kutlar","year":"2013","unstructured":"Kutlar A, Swerdlow PS, Meiler SE, Natrajan K, Wells LG, Clair B, et al. Pomalidomide In Sickle Cell Disease: Phase I Study Of a Novel Anti-switching Agent. Blood. 2013;122(21):777.","journal-title":"Blood"},{"issue":"1","key":"4146_CR6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1056\/NEJM197301042880108","volume":"288","author":"AG Motulsky","year":"1973","unstructured":"Motulsky AG. Frequency of sickling disorders in US blacks. N Engl J Med. 1973;288(1):31\u20133.","journal-title":"N Engl J Med"},{"key":"4146_CR7","unstructured":"Key Statistics About Multiple Myeloma. Available from:\u00a0https:\/\/www.cancer.org\/cancer\/multiple-myeloma\/about\/key-statistics.html"},{"issue":"11","key":"4146_CR8","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.15374","volume":"2","author":"D Lubeck","year":"2019","unstructured":"Lubeck D, Agodoa I, Bhakta N, Danese M, Pappu K, Howard R, et al. Estimated life expectancy and income of patients with sickle cell disease compared with those without sickle cell disease. JAMA Netw Open. 2019;2(11):e1915374.","journal-title":"JAMA Netw Open"},{"issue":"8","key":"4146_CR9","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1002\/ajh.26590","volume":"97","author":"SV Rajkumar","year":"2022","unstructured":"Rajkumar SV. Multiple myeloma: 2022 update on diagnosis, risk stratification, and management. Am J Hematol. 2022;97(8):1086\u2013107.","journal-title":"Am J Hematol"},{"key":"4146_CR10","volume":"22","author":"MB Zerdan","year":"2021","unstructured":"Zerdan MB, Diacovo MJ, Chaulagain CP. Challenges of managing multiple myeloma patients with sickle cell disease: a case report and review of literature. Am J Case Rep. 2021;22:e933470.","journal-title":"Am J Case Rep"},{"key":"4146_CR11","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1177\/0141076816651037","volume":"109","author":"OO Seminog","year":"2016","unstructured":"Seminog OO, Ogunlaja OI, Yeates D, Goldacre MJ. Risk of individual malignant neoplasms in patients with sickle cell disease: English national record linkage study. J R Soc Med. 2016;109:303\u20139.","journal-title":"J R Soc Med"},{"key":"4146_CR12","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1182\/blood-2010-11-319137","volume":"118","author":"SE Meiler","year":"2011","unstructured":"Meiler SE, Wade M, Kutlar F, Yerigenahally SD, Xue Y, Parseval LAM, et al. Pomalidomide augments fetal hemoglobin production without the myelosuppressive effects of hydroxyurea in transgenic sickle cell mice. Blood. 2011;118:1109\u201312.","journal-title":"Blood"},{"key":"4146_CR13","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.exphem.2017.10.003","volume":"58","author":"C Lanaro","year":"2018","unstructured":"Lanaro C, Franco-Penteado CF, Silva FH, Fertrin KY, Dos Santos JL, Wade M, et al. A thalidomide-hydroxyurea hybrid increases HbF production in sickle cell mice and reduces the release of proinflammatory cytokines in cultured monocytes. Exp Hematol. 2018;58:35\u20138.","journal-title":"Exp Hematol"},{"key":"4146_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.81430","volume":"12","author":"Y Lu","year":"2022","unstructured":"Lu Y, Wei Z, Yang G, Lai Y, Liu R. Investigating the efficacy and safety of thalidomide for treating patients with \u00df-thalassemia: a meta-analysis. Front Pharmacol. 2022;12:814302. https:\/\/doi.org\/10.3389\/fphar.2021.81430.","journal-title":"Front Pharmacol"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-025-04146-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-025-04146-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-025-04146-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T11:56:47Z","timestamp":1776254207000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-025-04146-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,27]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["4146"],"URL":"https:\/\/doi.org\/10.1007\/s12185-025-04146-2","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,27]]},"assertion":[{"value":"25 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}